Endogene
Bioinformatics · Drug Discovery
Overview
Endogene.bio generates high-resolution data from menstrual blood to accelerate disease understanding, patient stratification, and therapeutic discovery.
Official records
Funding and backers
Backers
2
Entrepreneur First, Frontline Ventures
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 23, 2022
Increased its share capital $3.1k · BODACC
Mar 2022
Website went live first capture in the Wayback Machine
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
TenSixty Biosciences expands the druggable oncology universe through epitope-level targeting and a biology-first therapeutic discovery…
Unlocking the full potential of chemoproteomics to accelerate the discovery of new small molecules that can change the course of disease.
ElectronRx delivers clinically validated digital biomarkers and continuous patient insights across COPD, Asthma, Interstitial Lung Disease…
Unlocking the diversity of biological life to accelerate sustainable development.
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Frontline VenturesVia a fund
Entrepreneur FirstVia a fund
530 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Whole genome methylation profiling of menstrual stem cells identifies novel biomarkers for endometriosis
Endometriosis, despite its high prevalence, is underdiagnosed and poorly managed due to lack of clinically validated biomarkers and pathophysiological insight. Menstrual blood-derived stem cells have been implicated in disease pathogenesis, but their diag
Read more
Report
Notion Where teams and agents work together
A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team
Read more
Report